Clinical Trials Directory

Trials / Conditions / Renal Osteodystrophy

Renal Osteodystrophy

19 registered clinical trials studyying Renal Osteodystrophy — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingPrecision Medicine Approaches to Renal Osteodystrophy
NCT05880914
Thomas Nickolas—
TerminatedThe Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients
NCT03960554
Thomas Nickolas, MD MSPhase 2
RecruitingDiagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function
NCT03716128
Ditte Hansen—
CompletedThe Effect of Etelcalcetide on CKD-MBD
NCT03960437
Thomas Nickolas, MD MSPhase 2
CompletedPathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
NCT03626246
Columbia University—
UnknownSystematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)
NCT02556216
Hannover Medical School—
UnknownClinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
NCT02147782
Shanghai University of Traditional Chinese Medicine—
WithdrawnKidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
NCT01665651
Bing ShuPhase 2
CompletedZoledronic Acid to Prevent Bone Loss After Kidney Transplantation
NCT01675089
University of Sao Paulo General HospitalPhase 4
UnknownSerum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Pati
NCT01382966
RFM Renal Treatment Services—
UnknownVitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients
NCT00752401
Medical University of ViennaPhase 3
CompletedRenal Osteodystrophy: A Fresh Approach
NCT00859612
Hartmut Malluche, MD—
CompletedLow Magnitude Mechanical Stimuli Effects on Bone Structure in ESRD
NCT00364234
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)N/A
CompletedCholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Dis
NCT00285467
Indiana University School of MedicineN/A
TerminatedKlotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
NCT00374712
Assistance Publique - Hôpitaux de Paris—
CompletedOsteopenia and Renal Osteodystrophy: Evaluation and Management
NCT00108394
US Department of Veterans AffairsPhase 4
Completed12-month Study of AMG 073 in Renal Osteodystrophy
NCT00527085
AmgenPhase 2
CompletedRegulation of Bone Formation in Renal Osteodystrophy
NCT00560300
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
CompletedPhase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis
NCT00004340
National Center for Research Resources (NCRR)Phase 2